Please ensure Javascript is enabled for purposes of website accessibility

Fox Channels May Go Dark on YouTube TV From Wednesday Over Payment Dispute

16 hours ago

California Republicans Sue to Block Congressional Redistricting Plan

16 hours ago

Leaders, Journalist Groups React to Israeli Gaza Strike That Killed Five Journalists

20 hours ago

Trump To Sign Executive Order Directing AG To Prosecute Flag Desecration

22 hours ago

Trump Signs Orders Aimed At Ending Cashless Bail Policies

22 hours ago

Fresno County DUI Crash Sends Car Into Embankment Near Highway 99

1 day ago

Wrongly Deported Migrant Abrego Again Detained by US Immigration Officials

1 day ago

Fresno County Wildfire Burns 3,338 Acres, Evacuation Orders Issued

1 day ago
US Regulators Post Positive Review of Pfizer Vaccine Data
gvw_ap_news
By Associated Press
Published 5 years ago on
December 8, 2020

Share

WASHINGTON — Documents released by U.S. regulators Tuesday confirmed that Pfizer’s vaccine was strongly protective against COVID-19 and appeared safe — offering the world’s first detailed look at the evidence behind the shots.

The positive review from the Food and Drug Administration sets the stage for a decision allowing the vaccine’s initial use within days. FDA regulators posted their analysis online even as across the Atlantic, Britain began vaccinating its oldest citizens with the shots, which were co-developed with BioNTech.

But the U.S. judges experimental vaccines in a unique way: On Thursday, the FDA will convene what’s essentially a science court that will debate — in public and livestreamed — just how strong the data backing the shots really is. That public vetting is considered key to bolstering confidence in the shots ahead of what’s expected to be the largest vaccination effort in U.S. history.

A panel of independent scientists will pick apart the FDA’s first-pass review before recommending whether the vaccine appears safe and effective enough for millions of Americans. The FDA typically follows the committee’s advice and if it gives the green light, the first recipients would be health care workers and nursing home residents, according to plans laid out by each state.

Pfizer CEO Albert Bourla declined to predict how quickly FDA might issue a decision.

“They need to take as much time as they need to feel comfortable. It’s very important for the trust of the vaccine from the people,” he said at a news conference in Geneva.

It’s one of several vaccines in the pipeline being tested in the hope of ending the pandemic. The FDA later this month will consider a COVID-19 vaccine by Moderna and the National Institutes of Health.

FDA’s Reviewers Agreed That the Shots Were Strongly Protective

Pfizer and its German partner BioNTech previously reported the shots appeared 95% effective at preventing mild to severe COVID-19 disease in a large, ongoing study. That’s based on the first 170 infections detected. Only eight of the infections were among volunteers given the real vaccine while the rest had received a dummy shot.

FDA’s reviewers agreed that the shots were strongly protective. And of special concern, they worked about as well in older adults, too, the agency confirmed. Among volunteers over age 55, there were three cases of COVID-19 infection who were vaccinated and 48 among placebo recipients. Five of the cases were among people 75 or older, and all had received the dummy shots.

While FDA noted that protection begins to appear two weeks after the first dose, full protection wasn’t calculated until after the second dose. No one yet knows how long that protection lasts, something the still unfinished study eventually will need to answer.

“We’re looking at the best possible data,” Dr. Paul Offit of Children’s Hospital of Philadelphia and an FDA adviser recently cautioned. “People worry, reasonably, how about six months later?”

In the two months that volunteers were tracked so far after the second dose, FDA’s reviewers said protection hadn’t begun waning.

The other critical issue: Safety. FDA reviewers said the vaccine has “a favorable safety profile, with no specific safety concerns” that would prevent a decision to allow emergency use.

A nurse holds a phial of the Pfizer-BioNTech COVID-19 vaccine at Guy’s Hospital in London, Tuesday, Dec. 8, 2020. U.K. health authorities rolled out the first doses of a widely tested and independently reviewed COVID-19 vaccine Tuesday, starting a global immunization program that is expected to gain momentum as more serums win approval. (AP Photo/Frank Augstein, Pool)

The FDA Found No Serious Side Effects Among the More Than 37,000 Volunteers

The main side effects are injection-site pain or flu-like reactions that indicate the immune system is revving up. Those tend to last a day or two and are most common after the second dose: More than half of adults under 55 experienced fatigue or headache, about a third reported chills or muscle pain, and 16% had a fever. Older adults were less likely to experience those reactions, and the FDA said they were considered severe in less than 5% of participants.

The FDA found no serious side effects among the more than 37,000 volunteers who’ve been tracked for at least two months after their last dose, the time period when historically any vaccination problems appear.

Some vaccine recipients experienced appendicitis and three developed Bell’s palsy, a temporary facial paralysis, during the study, but FDA said they occurred at rates common in the general population.

The study excluded volunteers with prior diagnoses of COVID-19, but researchers were anxious to learn how the vaccine would work in people who’ve already been infected and didn’t know it. Only 3% of study participants fell into that category, according to blood samples taken when they enrolled. There’s little data from that small subset of volunteers but, the FDA reviewers noted that previously infected people can be at risk of reinfection “and could benefit from vaccination.”

Another key question: how protective is the shot against severe cases of the disease? Four of the study’s 170 confirmed COVID-19 cases were severely ill, and only one of them had received vaccine instead of dummy shots. That participant was only classified as a severe case because of temporary low oxygen and wasn’t hospitalized.

Other Key Questions

Other key questions ahead of Thursday’s meeting:

–Were the shots adequately tested in Black, Hispanic and other communities hard-hit by the pandemic, to know how well the vaccine works in those populations?

–Does the vaccine protect against asymptomatic infection, or could the vaccinated still unknowingly spread the virus?

–What should pregnant women be told about vaccination, since they weren’t tested in Pfizer’s study?

Studies in children as young as 12 are just beginning.

Emergency vaccinations could begin before Pfizer’s 44,000-person study is complete, and answering some of those questions will require keeping that study going. Health authorities are wrestling with how to do so in a way that’s fair to placebo recipients who justifiably would want to get the real vaccine.

That access “is top of mind for many,” Pfizer and BioNTech recently wrote trial participants. The companies said they’re exploring ways to let placebo recipients switch to the vaccine group once they meet eligibility criteria for early access — if they’re health workers, for instance, or when the line opens for other essential workers or people over age 65.

On the safety front, study volunteers will be monitored for two years but even studies of tens of thousands of people can’t spot a complication that only strikes 1 in a million. So the government also is gearing up for unprecedented monitoring of recipients once emergency vaccinations get underway.

RELATED TOPICS:

DON'T MISS

What Are Fresno Real Estate Experts Predicting for 2025 and Beyond?

DON'T MISS

First California EV Mandates Hit Automakers This Year. Most Are Not Even Close

DON'T MISS

Trump Urges Cracker Barrel to Revert to Old Logo

DON'T MISS

California Farming Couple Seeks $300 Million for Aspen Estate

DON'T MISS

NW Fresno’s Newest Wine Lounge a ‘Quiet Alternative’ for Date Night

DON'T MISS

Renewal of CA Cap and Trade Program to Cut Emissions Fraught With Issues

DON'T MISS

UN Inquiry on Israeli Violence Hampered by Funding Shortfall, Document Shows

DON'T MISS

Trump Administration Cannot Sue Maryland Federal Judges Over Immigration Order, Judge Rules

DON'T MISS

US Threatens to Withhold Funding From States Over Truck Driver English Proficiency Rules

DON'T MISS

Why Did Board Fail to Stop Deficits From Nearly Sinking Fresno EOC?

DON'T MISS

Trump Takes His Fed Fight to Unprecedented Level With Effort to Fire Cook

DON'T MISS

Visalia DUI Crash Sends Truck Into Carl’s Jr., Driver Arrested

UP NEXT

California Farming Couple Seeks $300 Million for Aspen Estate

UP NEXT

Trump Administration Cannot Sue Maryland Federal Judges Over Immigration Order, Judge Rules

UP NEXT

US Threatens to Withhold Funding From States Over Truck Driver English Proficiency Rules

UP NEXT

Trump Takes His Fed Fight to Unprecedented Level With Effort to Fire Cook

UP NEXT

Trump Media, Crypto.com Announce Deal to Form Crypto Treasury Firm

UP NEXT

Fox Channels May Go Dark on YouTube TV From Wednesday Over Payment Dispute

UP NEXT

Trump Wants to Meet North Korea’s Kim This Year, He Tells South Korea

UP NEXT

Leaders, Journalist Groups React to Israeli Gaza Strike That Killed Five Journalists

UP NEXT

CA Bill To Give Interest On Insurance Payments To Homeowners

UP NEXT

Trump To Sign Executive Order Directing AG To Prosecute Flag Desecration

Renewal of CA Cap and Trade Program to Cut Emissions Fraught With Issues

27 minutes ago

UN Inquiry on Israeli Violence Hampered by Funding Shortfall, Document Shows

33 minutes ago

Trump Administration Cannot Sue Maryland Federal Judges Over Immigration Order, Judge Rules

39 minutes ago

US Threatens to Withhold Funding From States Over Truck Driver English Proficiency Rules

41 minutes ago

Why Did Board Fail to Stop Deficits From Nearly Sinking Fresno EOC?

42 minutes ago

Trump Takes His Fed Fight to Unprecedented Level With Effort to Fire Cook

43 minutes ago

Visalia DUI Crash Sends Truck Into Carl’s Jr., Driver Arrested

47 minutes ago

Trump Media, Crypto.com Announce Deal to Form Crypto Treasury Firm

51 minutes ago

New Fresno EOC Chief: ‘We Have to Eliminate Bleeding Programs’

12 hours ago

Fresno County Sheriff’s Deputy Arrested in Domestic Violence Case

12 hours ago

Trump Urges Cracker Barrel to Revert to Old Logo

President Donald Trump on Tuesday called on Cracker Barrel Old Country Store to go back to its old logo, weighing in on the restaurant compa...

6 minutes ago

President Donald Trump attends a meeting with South Korean President Lee Jae Myung (not pictured) at the Oval Office, at the White House, in Washington, D.C., U.S., August 25, 2025. (Reuters File)
6 minutes ago

Trump Urges Cracker Barrel to Revert to Old Logo

Billionaire California farmers Lynda and Stewart Resnick have listed their Aspen estate for $300 million, a price that could set a U.S. record for the most expensive home sale. (Shutterstock)
6 minutes ago

California Farming Couple Seeks $300 Million for Aspen Estate

Eden Wine Lounge
26 minutes ago

NW Fresno’s Newest Wine Lounge a ‘Quiet Alternative’ for Date Night

Chevron Refinery in Richmond, California
27 minutes ago

Renewal of CA Cap and Trade Program to Cut Emissions Fraught With Issues

Israeli soldiers sit on top of tanks at the Israel-Gaza border, as seen from Israel, August 26, 2025. (Reuters/Amir Cohen)
33 minutes ago

UN Inquiry on Israeli Violence Hampered by Funding Shortfall, Document Shows

U.S. flag and Judge gavel are seen in this illustration taken, August 6, 2024. (Reuters File)
39 minutes ago

Trump Administration Cannot Sue Maryland Federal Judges Over Immigration Order, Judge Rules

A drone view shows semi-trucks in San Diego, California, U.S., July 15, 2025. (Reuters File)
41 minutes ago

US Threatens to Withhold Funding From States Over Truck Driver English Proficiency Rules

Fresno Economic Opportunities Commission ignored red flags about overspending
42 minutes ago

Why Did Board Fail to Stop Deficits From Nearly Sinking Fresno EOC?

Search

Help continue the work that gets you the news that matters most.

Send this to a friend